Search Within

Larry Norton

  1. "Cardiology"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (10)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (24)
  2. Breast Medicine Service (24)
  3. Cardiology (24)
  4. Department of Medicine (24)
  5. Division of Subspecialty Medicine (24)
  6. Solid Tumor Oncology Division (24)

More Groups

People
  1. Clifford Hudis (23)
  2. Chau Dang (22)
  3. Richard Steingart (18)
  4. Maura Dickler (13)
  5. Steven Sugarman (13)
  6. Sujata Patil (13)

More People

Years
  1. 2017 (2)
  2. 2016 (2)
  3. 2013 (4)
  4. 2012 (1)
  5. 2011 (3)
  6. 2010 (1)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Cancer Research (5)
  3. Breast Cancer Research and Treatment (3)
  4. Clinical Cancer Research (2)
  5. Annals of Oncology (1)
  6. Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. American Association for Cancer Research (7)
  3. Springer (3)
  4. Oxford University Press (2)
  5. Wiley Blackwell (1)

Results (24)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Longer follow-up on cardiac safety and distant disease free survival of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab in patients with early-stage HER2-positive breast cancer
    Meeting Abstract

    Wang, R.; Yu, A. F.; Steingart, R.; Patil, S.; Baselga, J.; Norton, L.; Hudis, C.; Dang, C. T.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Pathologic complete response with neoadjuvant doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab and pertuzumab in patients with HER2-positive early stage breast cancer: A single center experience
    Journal Article

    Singh, J. C.; Mamtani, A.; Barrio, A.; Morrow, M.; Sugarman, S.; Jones, L. W.; Yu, A. F.; Argolo, D.; Smyth, L. M.; Modi, S.; more...
    The Oncologist (2017)

    Fulltext@MSK | Save
  • Pathologic complete response rate with doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-positive early stage breast cancer: A single institution experience
    Meeting Abstract

    Singh, J. C.; Sugarman, S.; Jones, L.; Boafo, C.; Patil, S.; Schweber, S.; Yu, A.; Argolo, D.; Modi, S.; Iyengar, N.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Cardiac surveillance guidelines for trastuzumab-containing therapy in early-stage breast cancer: Getting to the heart of the matter
    Journal Article

    Dang, C. T.; Yu, A. F.; Jones, L. W.; Liu, J.; Steingart, R. M.; Argolo, D. F.; Norton, L.; Hudis, C. A.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Longer-term cardiac safety and outcomes of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC)
    Meeting Abstract

    Morris, P. G.; Iyengar, N. M.; Patil, S.; Chen, C.; Abbruzzi, A.; Lehman, R. J.; Steingart, R.; Oeffinger, K. C.; Lin, N.; Moy, B.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer with cardiac biomarker data
    Meeting Abstract

    Iyengar, N. M.; Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Longer-term cardiac safety and outcomes of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC)
    Meeting Abstract

    Iyengar, N. M.; Morris, P. G.; Patil, S.; Chen, C.; Abbruzzi, A.; Lehman, R. J.; Steingart, R.; Oeffinger, K. C.; Lin, N. U.; Moy, B.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer
    Journal Article

    Morris, P. G.; Iyengar, N. M.; Patil, S.; Chen, C.; Abbruzzi, A.; Lehman, R.; Steingart, R.; Oeffinger, K. C.; Lin, N.; Moy, B.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer
    Journal Article

    Gajria, D.; Gonzalez, J.; Feigin, K.; Patil, S.; Chen, C.; Theodoulou, M.; Drullinsky, P.; D'Andrea, G.; Lake, D.; Norton, L.; more...
    Breast Cancer Research and Treatment (2012)

    Fulltext@MSK | Save
  • Long-term cardiac safety and outcomes of dose-dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC)
    Meeting Abstract

    Dang, C. T.; Morris, P. G.; Patil, S.; Chen, C.; Abbruzzi, A.; Lehman, R.; Steingart, R.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save